CTLA-4 – two pathways to anti-tumour immunity?
| dc.contributor.author | Ward, Frank | |
| dc.contributor.author | Kennedy, Paul T | |
| dc.contributor.author | Al-Fatyan, Farah Muthanna | |
| dc.contributor.author | Dahal, Lekh Nath | |
| dc.contributor.author | Abu Eid, Rasha | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Microbiology and Immunity | en |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
| dc.contributor.institution | University of Aberdeen.Dental Education | en |
| dc.date.accessioned | 2025-07-11T12:49:01Z | |
| dc.date.available | 2025-07-11T12:49:01Z | |
| dc.date.issued | 2025 | |
| dc.description | Open Access via the Oxford University Press agreement Acknowledgements The Editor-in-Chief, Tim Elliott, and handling editor, Jeanette Leusen, would like to thank reviewers, Simon Milling and an anonymous reviewer, for their contribution to the publication of this article. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 10 | |
| dc.format.extent | 1093031 | |
| dc.identifier | 302077126 | |
| dc.identifier | fda0ce37-f0fa-41b6-b595-cb7aaaafc9f3 | |
| dc.identifier | 40265076 | |
| dc.identifier | 105003549299 | |
| dc.identifier.citation | Ward, F, Kennedy, P T, Al-Fatyan, F M, Dahal, L N & Abu Eid, R 2025, 'CTLA-4 – two pathways to anti-tumour immunity?', Immunotherapy Advances, vol. 5, no. 1, ltaf008. https://doi.org/10.1093/immadv/ltaf008 | en |
| dc.identifier.doi | 10.1093/immadv/ltaf008 | |
| dc.identifier.iss | 1 | en |
| dc.identifier.issn | 2732-4303 | |
| dc.identifier.uri | https://hdl.handle.net/2164/25689 | |
| dc.identifier.vol | 5 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Immunotherapy Advances | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | immune checkpoint inhibitors | en |
| dc.subject | CTLA-4 | en |
| dc.subject | regulatory T cells (Treg) | en |
| dc.subject | soluble CTLA-4 (sCTLA-4) | en |
| dc.subject | RC0254 Neoplasms. Tumors. Oncology (including Cancer) | en |
| dc.subject | Supplementary Data | en |
| dc.subject | DAS | en |
| dc.subject.lcc | RC0254 | en |
| dc.title | CTLA-4 – two pathways to anti-tumour immunity? | en |
| dc.type | Journal item | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Ward_etal_ITA_CTLA-4_Two_Pathways_VOR.pdf
- Size:
- 1.04 MB
- Format:
- Adobe Portable Document Format
